Jean-Hugues Dalle, MD, PHD^1,2, Sylvie Chevret^3*, Cécile Renard, MD^4*, Virginie Gandemer^5*, Benedicte Bruno^6*, Flore Sicre De Fontbrune^7*, Marie Angoso, MD^8*, Fanny Rialland Battisti, MD^9*, Lynda Maafa^2*, Isabelle Brindel, PhD^10*, Nimrod Buchbinder, MD^11*, Mony Fahd, MD MSc^12,13* and Regis Peffault De Latour^14,15*

¹Department of Pediatric Hematology and Immunology, Robert-Debré Academic Hospital ,, Assistance Publique des Hôpitaux de Paris (APHP), Paris, France
²Saint-Louis Hospital, GHU AP-HP Nord Université Paris Cité, French National Reference Center for Severe Aplastic Anemia, Paris, France
³Biostatistics and Medical Information Department, Saint Louis Hospital, Assistance Publique — Hôpitaux de Paris (AP-HP), Paris, France
⁴Institute of Hematology and Pediatric Oncology, Lyon, France
⁵Pediatric BMT Unit, Rennes, France
⁶Chru Lille, Jeanne De Flandre Hématologie Pédiatrique, Lille, FRA
⁷Service Hematologie Greffe, Centre de Reference des Aplasies Medullaires Acquises et Constitutionnelles, Hôpital Saint-Louis, Assistance Publique Hôpitaux de Paris, Paris, France
⁸CHU Bordeaux, bordeaux, France
⁹Hématologie et oncologie pédiatrique, CHU Hôtel Dieu, Nantes, FRA
¹⁰Saint-Louis Hospital, GHU AP-HP Nord Université Paris Cité, French National Reference Center for Severe Aplastic Anemia, PARIS, France, FRA
¹¹Department of Pediatric Hematology and Oncology, Rouen University Hospital, Rouen, France
¹²Saint-Louis Academic Hospital, GHU Ap-HP Nord Université Paris Cité, French National Reference Center for Severe Aplastic Anemia, Paris, France
¹³Hematology and Immunology Pediatric Department, Robert-Debré Academic Hospital, GHU AP-HP Nord Université Paris Cité, Paris, France
¹⁴BMT unit, Hôpital Saint-Louis,, Paris, France
¹⁵French Référence Center for Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria, Paris, France

Moazzam Shahzad, MD^1,2, Muhammad Kashif Amin, MD^1,3,4*, Aqeeb Ur Rehman, MD^1,3*, Aleenah Mohsin^1,3*, Matthew McGuirk^1,3*, Sibgha Gull Chaudhary, MD^1,3,4*, Iqra Anwar, MBBS^1,3*, Haitham Abdelhakim, MD^1,5, Anurag K. Singh, MD^1,3,4, Mehdi Hamadani, MD^1,6, Joseph P. McGuirk, DO^1,3,4 and Muhammad Umair Mushtaq^3,4,7

¹Mikael Rayaan Foundation Global Health Consortium, Kansas City, KS
²Department of Oncological Sciences, H. Lee Moffitt Cancer Center, University of South Florida, Tampa, FL
³Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
⁴US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS
⁵Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Cancer Center, Westwood, KS
⁶Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
⁷MRF, Kansas City

Seidai Tanaka, MD^1*, Hiroshi Okamura, MD, PhD^1,2*, Soichiro Nakako, MD^1*, Makoto Moriguchi, MD^1*, Kentaro Ido, MD, PhD^1,2*, Kazuki Sakatoku, MD, PhD^1*, Yosuke Nakaya, MD, PhD^1,2*, Mirei Horiuchi, MD^1*, Yosuke Makuuchi, MD, PhD^1*, Masatomo Kuno, MD, PhD^1*, Mitsutaka Nishimoto, MD, PhD^1*, Yasuhiro Nakashima, MD, PhD^1*, Mika Nakamae, MD, PhD^1,2*, Masayuki Hino, MD, PhD^1,2 and Hirohisa Nakamae, MD, PhD^1,2*

¹Department of Hematology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan
²Department of Laboratory Medicine and Medical Informatics, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan

Armin Rashidi, MD, PhD¹, Hakan Gem, DDS, PhD^2*, Maryam Ebadi, MD³, Gale Sebastian, DDS^4*, Rania Abasaeed, DDS^4*, Samuel Minot, PhD^5*, Michele Lloid^4* and David R Dean, DDS^4*

¹Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
²School of Dentistry, University of Washington, Seattle, WA
³Department of Radiation Oncology, University of Washington and Fred Hutch Cancer Center, Seattle, WA
⁴Department of Oral Medicine, Fred Hutchinson Cancer Center, Seattle, WA
⁵Microbiome Research Initiative, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA

Ruah Alyamany, MD^1,2, Ahmed Alnughmush, MD^1,2, Mats Remberger, PhD^3*, Fotios Michelis, MD^2,4*, Arjun D. Law, MD^1,2*, Wilson Lam, MD^2,4, Dennis Dong Hwan Kim, MD, PhD^1,2, Ivan Pasic, MD^2,4*, Igor Novitzky-Basso, MD^2,4*, Armin Gerbitz, MD, PhD^1,2*, Rajat Kumar, MD PhD^2,4, Jonas Mattsson, MD, PhD^2,5* and Auro Viswabandya, MD^1,2

¹Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
²Department of Medicine, University of Toronto, Toronto, ON, Canada
³Department of Medical Sciences, Uppsala University Hospital, Uppsala, Sweden
⁴Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada, Toronto, ON, Canada
⁵Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada

Cécile Pochon^1,2*, Laura M. Moser^3*, Ulrike Poetschger^4*, Peter Bader³, Herbert Pichler^4,5*, Adriana Balduzzi, MD^6,7, Julia Palma^8*, Jean-Hugues Dalle, MD, PHD⁹, Jochen Buechner^10*, Jacek Wachowiak^11*, Marianne Ifversen^12*, Tayfun Güngör^13*, Petr Sedlacek, MD, PhD^14*, Gergely Krivan^15*, Marc Bierings, MD, PhD¹⁶, Akif Yesilipek^17*, Cristina Díaz De Heredia^18*, Marleen Renard^19*, Jacek Toporski^20*, Peter Svec^21*, Franco Locatelli, MD^22,23 and Christina Peters^4,5*

¹Nancy University Hospital, Pediatric onco-hematology department, Vandoeuvre lès Nancy, France
²Lorraine University, IMOPA 7365 CNRS-UL, Vandoeuvre lès Nancy, France
³Goethe University Frankfurt, University Hospital, Department of Pediatrics, Division for Stem Cell Transplantation and Immunology, Frankfurt am Main, Germany
⁴St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria
⁵Medical University of Vienna, St. Anna Children's Hospital, Department of Pediatrics and Adolescent Medicine, Vienna, Austria
⁶Fondazione IRCCS San Gerardo dei Tintori, Pediatric Hematopoietic Stem Cell Transplant Unit, Monza, Italy
⁷University of Milano-Bicocca, School of Medicine and Surgery, Monza, Italy
⁸Hospital Luis Calvo Mackenna, Santiago, Chile
⁹GHU APHP Nord - Université Paris Cité, Robert Debré Hospital, Pediatric Hematology and Immunology Department, Paris, France
¹⁰Oslo University Hospital, Department of Pediatric Hematology and Oncology, Oslo, Norway
¹¹Poznań University of Medical Sciences, Department of Pediatric Oncology, Hematology and Transplantology, Poznan, Poland
¹²Copenhagen University Hospital Rigshospitalet, Department of Pediatrics and Adolescent Medicine, Copenhagen, Denmark
¹³Hematology/Oncology/Immunology, Gene Therapy, and Stem Cell Transplantation, University Children's Hospital Zurich-Eleonore Foundation & Children's Research Center, Zürich, Switzerland
¹⁴University Hospital Motol, Department of Paediatric Haematology and Oncology, Prague, Czech Republic
¹⁵National Institute of Hematology and Infectious Diseases, Central Hospital of Southern Pest, Pediatric Hematology and Stem Cell Transplantation Department, Budapest, Hungary
¹⁶Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands
¹⁷Medical Park Antalya Hospital, Antalya, Turkey
¹⁸Pediatric Oncology and Hematology Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain
¹⁹University Hospital Leuven, Department of Paediatric Oncology, Leuven, Belgium
²⁰Karolinska University Hospital, Department Cell Therapy and Allogeneic Stem Cell Transplant (CAST), Stockholm, Sweden
²¹National Institute of Children's Diseases, Comenius University, Department of Pediatric Hematology and Oncology, Bratislava, Slovakia
²²IRCCS Ospedale Pediatrico Bambino Gesù, Catholic University of the Sacred Heart, Rome, Italy
²³Catholic University of the Sacred Heart, Rome, Italy

Nihar Desai, MBBS, MD, DM^1*, Arjun Law, MD^2,3, Igor Novitzky-Basso, MD^2,4*, Ivan Pasic, MD^2,4*, Wilson Lam, MD^2,4, Fotios Michelis, MD^2,4*, Armin Gerbitz, MD, PhD^2,5*, Dennis Dong Hwan Kim, MD, PhD^2,6, Rajat Kumar, MD PhD^2,4, Jonas Mattsson, MD, PhD^2,7* and Auro Viswabandya, MD^2,5

¹Princess Margaret Cancer Center, Lucknow, India
²Department of Medicine, University of Toronto, Toronto, ON, Canada
³Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada, Toronto, Canada
⁴Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada, Toronto, ON, Canada
⁵Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
⁶Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
⁷Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada

Jessica S. Little, MD^1,2,3*, Kyle Hebert, MS^4*, Donna S. Neuberg, ScD⁴, Sarah Nikiforow, MD, PhD^5,6, Mahasweta Gooptu, MD^6,7, Roman M. Shapiro, MD^5,6, John Koreth, MD, MBBS, PhD, DPhil^5,6, Joseph H. Antin, MD⁶, Corey S. Cutler, MD, MPH^6,8, Robert J. Soiffer, MD^6,9, Jerome Ritz, MD^6,8, Rizwan Romee, MD^5,6, Vincent T. Ho, MD^6,8*, Nicolas C Issa, MD^2,10,11*, Lindsey R. Baden, MD^2,8,12*, Remy Dulery, MD, PhD^6,8,13* and Susan E Prockop, MD^6,14*

¹Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA
²Harvard Medical School, Boston
³Department of Medical Oncology, Dana-Farber Center Institute, Boston, MA
⁴Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
⁵Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
⁶Harvard Medical School, Boston, MA
⁷Department of Hematology/Oncology, Dana-Farber Cancer Institute, Boston, MA
⁸Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
⁹Dana-Farber Cancer Inst., Boston, MA
¹⁰Department of Medical Oncology, Dana-Farber Cancer Institute, Boston
¹¹Division of Infectious Diseases, Brigham & Women's Hospital, Boston, MA
¹²Division of Infectious Diseases, Brigham and Women's Hospital, Boston
¹³Clinical Hematology and Cellular Therapy, Sorbonne University, Saint-Antoine Hospital, Assistance Publique - Hôpitaux de Paris, INSERM UMRs 938, Paris, Île-de-France, France
¹⁴Stem Cell Transplant Program, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA

Hongye Gao^1*, Jiali Wang^2*, Zhuoxin Zhang^1*, Hao Zhang, MD^3*, Xin Du^4*, Yao Liu⁵, Dehui Zou^1*, Xianmin Song⁶ and Erlie Jiang, PhD¹

¹Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Scienfor Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
²Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Scienfor Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianijin, China
³Affiliated Hospital of Jining Medical University, Jining, China
⁴Department of Hematology, Shenzhen Second People's Hospital, Shenzhen, China
⁵Chongqing University Cancer Hospital, Chongqing, China
⁶Department of Hematology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Gerardo Lopez Hernandez, MD^1,2, Alberto Olaya Vargas, MD^3*, Rosa Maria Nidesha Ramírez Uribe, MD^4*, Haydeé del Pilar Salazar Rosales, MD^3*, Karla Maldonado Silva, MD^5*, Isabel Martínez Talavera, MD^6* and José Luis Salazar Bailón, MD^7*

¹Hematopoietic Stem Cell Transplant and Cell Therapy Department, The National Institute of Pediatrics, Mexico City, Benito Juárez, Mexico
²Bone Marrow Transplant Service, Star Medica Hospital Infantil Privado, México City, Mexico
³Hematopoietic Stem Cell Transplant and Cell Therapy Department, The National Institute of Pediatrics, Ciudad de Mexico, DF, Mexico
⁴Hematopoietic Stem Cell Transplant and Cell Therapy Department, The National Institute of Pediatrics, Ciudad De México, Ciudad de Mexico, MEX
⁵Blood Bank Service, The National Institute of Pediatrics, Ciudad de Mexico, DF, Mexico
⁶Blood Bank Service, The National Institute of Pediatrics, Ciudad de Mexico, Distrito Federal, MEX
⁷Blood Bank Department, Instituto Nacional de Pediatría, México City, Mexico

Ariadna Pérez^1*, Monica Cabrero Calvo, MD^2*, Juan Montoro, MD, PhD^3*, Miriam Sanchez-Escamilla^4*, Maria Angeles Cuesta^5*, Valle Gomez G De Soria, MD^6*, Pedro Gonzalez-Sierra^7*, Karem Humala^8*, Oriana López Godino^9*, Maria Luisa Palacios-Berraquero^10*, Lucía López-Corral^11*, Jaime Sanz^12*, Maria Jesus Pascual^13*, Jose Luis Piñana, MD, PhD^14*, Arancha Bermúdez^15*, José Mª Bellón^16*, Silvia Filaferro^17*, Guillermo Orti, MD, PhD^18*, Pascual Balsalobre^19* and Carlos Solano, MD, PhD²⁰

¹Hematology Department, Hospital Clínico de Valencia, Valencia, Spain
²Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca (IBSAL), Centro de Investigación del Cancer (IBMCC-USAL, CSIC), Salamanca, Spain
³Hematology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain
⁴Hematology Dpt., Hospital Univ. Marqués de Valdecilla, Santander, Spain
⁵Hematology Dpt., Hospital Regional Universitario de Málaga, Malaga, ESP
⁶Hospital Universitario La Princesa, Madrid, Spain
⁷Hematology Department, Hospital Universitario Virgen de las Nieves de Granada, Granada, ESP
⁸Hematology Dpt., Hospital Universitario La Paz, Madrid, ESP
⁹Hematology Dpt., Hospital Univ. Morales Meseguer, Murcia, Spain
¹⁰Hospital Univ. Ramón y Cajal, Madrid, Spain
¹¹University Hospital of Salamanca, Salamanca, Spain
¹²Hematology Department, Hospital Universitari i Politècnic La Fe, VALENCIA, ESP
¹³Hospital Regional Universitario de Málaga, Malaga, Spain
¹⁴Servicio de Hematología, Hospital Clínico Universitario de Valencia, Valencia, Spain
¹⁵Hospital Marques de Valdecilla (IDIVAL), Santander, Spain
¹⁶Biostatistics, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain
¹⁷Grupo Español de Trasplante de Progenitores Hematopoyéticos y Terapia Celular (GETH-TC) Data Office, Madrid, Spain
¹⁸Vall D' Hebron University Hospital, Barcelona, Spain
¹⁹Grupo Español de Trasplante de Progenitores Hematopoyéticos y Terapia Celular (GETH-TC), Madrid, AL, Spain
²⁰Hematology Department, Hematology Department, Hospital Clínico Universitario-INCLIVA, Valencia, Spain

Shin-ichiro Fujiwara^1*, Shunto Kawamura, MD^2*, Shun-Ichi Kimura, MD^2*, Junko Takeshita, MD^2*, Ryutaro Tominaga^3*, Daizo Yokoyama^3*, Atsuto Noguchi^3*, Shuka Furuki^3*, Shunsuke Koyama^3*, Rui Murahashi^3*, Hirotomo Nakashima^3*, Kazuki Hyodo^3*, Yumiko Toda^3*, Kento Umino^3*, Daisuke Minakata, MD^4*, Ayumi Gomyo^2*, Machiko Kusuda, MD^2*, Masahiro Ashizawa^5*, Chihiro Yamamoto, MD, PhD^3*, Kaoru Hatano^3*, Kazuya Sato, MD, PhD³, Ken Ohmine, MD, PhD^3*, Hideki Nakasone, MD, PhD², Shinichi Kako, MD, PhD² and Yoshinobu Kanda, MD, PhD^3*

¹Division of Cell Transplantation and Transfusion, Jichi Medical University, Shimotsuke, Japan
²Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan
³Division of Hematology, Department of Medicine, Jichi Medical University, Shimotsuke, Japan
⁴Division of Hematology, Department of Medicine, Jichi Medical University, Shimotsuke City, Tochigi, Japan, Japan
⁵Jichi Medical University Saitama Medical Center, Saitama-Shi, Japan

Mariola A Vazquez-Martinez, MD¹, Teresa Caprice, PA-C^1*, Fnu Amisha, MD^2,3, Andrew Almaraz^4*, Jongphil Kim, PhD^5*, Biwei Cao, MS^5*, Mohammed E Alomar^1*, Farhad Khimani, MD^6*, Asmita Mishra, MD, MBA⁶, Michael Nieder, MD^6*, Aleksandr Lazaryan, MD, MPH, PhD⁶, Jose L. Ochoa-Bayona, MD^4*, Taiga Nishihori, MD⁷, Sayeef Mirza, MD, MPH⁷, Rawan Faramand, MD⁶, Lia Perez, MD^6*, Claudio Anasetti, MD^6*, Joseph A. Pidala, MD, PhD⁶, Nelli Bejanyan, MD⁶ and Hany Elmariah, MD, MS⁶

¹Moffitt Cancer Center, Tampa
²Department of Hematology and Oncology, USF Morsani/H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
³Morsani College of Medicine, University of South Florida, Tampa, FL
⁴Moffitt Cancer Center, Tampa, FL
⁵Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁶Department of Blood and Marrow Transplantation and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁷Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL

Ignacio Gómez-Centurión, MD^1,2*, Carmen García Menéndez^3*, Rebeca Bailen^1,2*, Paula Fernández-Caldas^4*, Lucia Castilla Garcia^5*, Pablo Silva^6*, Carmen López Fresneña^7*, Ramon García^7* and Mi Kwon, MD, PhD^2,8

¹Health Research Institute Gregorio Marañón, Madrid, Spain
²General University Hospital Gregorio Marañón, Madrid, Spain
³General Universitary Hospital Gregorio Marañón, Madrid, Spain
⁴Hematology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain
⁵Hospital General Universitario Gregorio Marañon, Madrid, Spain
⁶Hematology Dpt., Hosp. Gen. Univ. Gregorio Marañón, Madrid, Spain
⁷Hematology, General Universitary Hospital Gregorio Marañón, Madrid, Spain
⁸Institute of Health Research Gregorio Marañon, Madrid, Spain

Ana L. Varela-Constantino, MD^1*, Michelle Morcos, MD², Andres Noyola-Perez, MD³, Nereida Méndez-Ramírez^4*, Eli Fuentes-Chavez^4*, Rosario Salazar-Riojas^4*, César Homero Gutierrez-Aguirre, MD^5*, Olga Cantu, MD^5*, Perla Rocio Colunga Pedraza^6*, Luz Tarin-Arzaga, MD^7*, Xitlaly Judith Gonzalez Leal, MD⁸, Elías Eugenio Gonzalez-López, MD^9*, David Gomez-Almaguer, MD¹⁰ and Andres Gomez-De Leon, MD^11,12

¹Hematology and Oncology Department, Clínica Gómez Almaguer y Tec Salud, Monterrey, EM, Mexico
²Hematology Service, Hospital Universitario "Dr. Jose Eleuterio Gonzalez", Universidad Autónoma de Nuevo León, Monterrey, Mexico, Monterrey, Mexico
³Hematology Department, Universidad Autonoma de Nuevo Leon (UANL). Facultad de Medicina y Hospital Universitario “Dr. José Eleuterio González”, Monterrey, Mexico
⁴Universidad Autónoma de Nuevo León, Facultad de Medicina y Hospital Universitario Dr. José Eleuterio González, Monterrey, NL, Mexico
⁵Servicio de Hematología, Hospital Universitario "Dr. Jose Eleuterio Gonzalez", Universidad Autónoma de Nuevo León, Monterrey, NL, Mexico
⁶Universidad Autónoma de Nuevo León, Hospital Universitario Doctor José Eleuterio Gonzalez, Monterrey, NL, Mexico
⁷Servicio de Hematología, Hospital Universitario “Dr. José Eleuterio González”, Universidad Autónoma de Nuevo León, Monterrey, NL, Mexico
⁸Tec Salud, Instituto Tecnológico de Estudios Superiores de Monterrey, Monterrey, NL, Mexico
⁹Clínica Gómez-Almaguer, Monterrey, NL, Mexico
¹⁰Hematology Service, Hospital Universitario "Dr. Jose Eleuterio Gonzalez", Universidad Autónoma de Nuevo León, Monterrey, Mexico
¹¹Clínica Gómez Almaguer, Monterrey, Mexico
¹²Servicio de Hematología, Hospital Universitario "Dr. Jose Eleuterio Gonzalez", Universidad Autónoma de Nuevo León, Monterrey, Mexico

Man Chen^1*, Wei Zhao^2*, Minjing Fu^3*, Peihua Lu, MD⁴ and Hui Wang, MD⁵

¹Beijing Lu Daopei Hospital, Beijing, CHN
²HSCT department, Beijing Lu Daopei Hospital, Beijing, CHN
³Beijing Ludaopei Hospital, Beijing, CHN
⁴Beijing Lu Daopei Institute of Hematology, Beijing, China
⁵Hehei Yanda Lu Daopei Hospital, Beijing, Beijing, China

Gonzalo De Luna, MD^1*, Nicolas Hebert, PhD^2*, Ivan Sloma, PhD^3*, Florence Beckerich, MD^4*, Rabah Redjoul, MD^4*, Anoosha Habibi, MD¹, Mathieu Leclerc, MD, PhD^4*, Vincent Parinet, MD^4*, Christine Robin, MD^4*, Cécile Pautas, MD^4*, Stephane Moutereau, MD^5*, Fatima Bensiradj, MD^1*, Meghan Perkins, PhD^2*, France Pirenne, MD, PhD^6,7, Dehbia Menouche, MD^8*, Pablo Bartolucci, MD, PhD^1,2* and Sébastien Maury, MD, PhD^4*

¹Sickle Cell Referral Center, UMGGR, Department of Internal Medicine, Henri-Mondor University Hospital- UPEC, AP-HP, Créteil, France
²Université Paris-Est Créteil, INSERM U955, IMRB, Laboratory of excellence LABEX GRex, Créteil, France
³Hematology and Immunology Department, Henri Mondor University Hospital, UPEC, IMRB, Assistance Publique Hopitaux de Paris, Créteil, France
⁴Hematology Department, Henri Mondor University Hospital, UPEC, IMRB, Assistance Publique Hopitaux de Paris, Créteil, France
⁵Department of Biochemistry, Henri-Mondor University Hospital- UPEC, AP-HP, Creteil, France
⁶Transfusion et maladies du globule rouge - Equipe Pirenne, Institut Mondor de Recherche Biomedicale (IMRB), Creteil, France
⁷Etablissement Francais Du Sang - Université Paris-Est Créteil Hospital, Creteil, France
⁸Apheresis, Hopital Henri Mondor, Créteil, France

Julia Möhlmann^1*, Lisanne Ploeg, van der^1*, Jurgen Langenhorst, PhD^2*, Tim Bognar^1*, Kim Elst, van der, PhD^1*, Marc Bierings, MD, PhD³, Alwin D.R. Huitema^4,5,6*, Aurelia Vries Schultink, de, PhD^1* and Caroline Lindemans, MD, PhD^7,8

¹Dept. of Clinical Pharmacy, University Medical Centre Utrecht, Utrecht, Netherlands
²Pharmetheus A.B., Uppsala, Sweden
³Dept. of Stem Cell Transplantation, Princess Máxima Centre for Paediatric Oncology, Utrecht, Netherlands
⁴University Medical Center Utrecht, Utrecht, Netherlands
⁵Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands
⁶Netherlands Cancer Institute, Amsterdam, Netherlands
⁷Dept. of Stem Cell Transplantation, Princess Máxima Center For Pediatric Oncology, Utrecht, Netherlands
⁸Dept. of Paediatrics, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, Netherlands

Muhammad Umair Mushtaq^1,2,3, Amir Kasaeian^1,3*, Sibgha Gull Chaudhary, MD^1,2,3*, Muhammad Kashif Amin, MD^1,2,3*, Naghmeh Khavandgar^1,3*, Hediyeh Alemi^1,3*, Muhammad Fareed Khalid, MD^1,3*, Iqra Anwar, MBBS^1,3*, Matthew McGuirk^1,3*, Anurag K. Singh, MD^1,2,3, Joseph P. McGuirk, DO^1,2,3 and Moazzam Shahzad, MD^3,4

¹Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
²US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS
³Mikael Rayaan Foundation Global Health Consortium, Kansas City, KS
⁴Department of Oncological Sciences, H. Lee Moffitt Cancer Center, University of South Florida, Tampa, FL

Alexander Ruzic, B.Sc.^1*, Emily Trus, BEng (candidate)^1*, Gregory R Pond, PhD^2*, Ram Vasudevan Nampoothiri, MD DM MRCP(UK)^3*, Vinita Dhir, MD⁴, Andrew Poskus, MD^5*, Louise Bordeleau, MD MSc FRCPC^6* and Michael Trus, MD, PhD, FRCPC⁷

¹Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada
²Department of Oncology, McMaster University, Hamilton, Canada
³Transplant and Cellular Therapy Program, University of Ottawa, Ottawa, ON, Canada
⁴Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada
⁵The Ottawa Hospital, University of Ottawa, Ottawa, ON, Canada
⁶Department of Oncology, McMaster University, Hamilton, ON, Canada
⁷Hamilton Health Sciences Henderson Hospital Site, Hamilton, ON, Canada

Aswin Anand Pai, MSc, PhD^1*, Nieshanth Parthiban^2*, Nayanthara Bijukumar^1*, Rachel Mariam Renji^1*, Manoj A^1*, Sujith Karumathil^1*, Kavitha M Lakshmi, MSc^1*, Sushil Selvarajan, MD, DM^1*, Anu Korula, MD, DM, MRCP^3*, Fouzia NA, MD, DM^1*, Aby Abraham, MD, DM^1*, Alok Srivastava, MD, FRACP, FRCPA, FRCP¹, Vikram Mathews, MD, DM⁴, Biju George, MD, DM¹, Uday Kulkarni, MD, DM¹ and Poonkuzhali Balasubramanian, MSc, PhD¹

¹Department of Haematology, Christian Medical College Ranipet Campus, Ranipet, India
²Christian Medical College Vellore, Vellore, India
³Department of Haematology, Christian Medical College & Hospital, Vellore, India
⁴Department of Haematology, Christian Medical College Vellore, Ranipet Campus, India

Armin Rashidi, MD, PhD¹, Maryam Ebadi, MD², Hakan Gem, DDS, PhD^3*, Yolanda D Tseng, MD^2*, Gale Sebastian, DDS^4*, Rania Abasaeed, DDS^4*, Michele Lloid^4*, Samuel Minot, PhD^5* and David R Dean, DDS^4*

¹Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
²Department of Radiation Oncology, University of Washington and Fred Hutch Cancer Center, Seattle, WA
³School of Dentistry, University of Washington, Seattle, WA
⁴Department of Oral Medicine, Fred Hutchinson Cancer Center, Seattle, WA
⁵Microbiome Research Initiative, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA

Abida Babu, MBBS¹, Kathryn Bower, MD^2*, Madiha Siraj, MD^3*, Biwei Cao, MS^4*, Jongphil Kim, PhD^2*, Hany Elmariah, MD, MS⁵, Rawan Faramand, MD⁵, Sayeef Mirza, MD, MPH⁵, Lia Perez, MD^5*, Asmita Mishra, MD, MBA⁵, Farhad Khimani, MD^5*, Jose L. Ochoa-Bayona, MD^1*, Michael Nieder, MD^5*, Taiga Nishihori, MD¹, Joseph A. Pidala, MD, PhD⁵ and Nelli Bejanyan, MD⁵

¹Moffitt Cancer Center, Tampa, FL
²Moffitt Cancer Center, Tampa
³University of South Florida, Tampa, FL
⁴Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁵Department of Blood and Marrow Transplantation and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL

Laura Prin Felix^1*, Maxime Jullien, MD^2*, Amandine Le Bourgeois, MD^2*, Alice Garnier, MD^3*, Pierre Peterlin^2*, Sophie Vantyghem, MD^2*, Aude-Marie Fourmont, MD^2*, Thierry Guillaume, MD, PhD^2* and Patrice Chevallier, MD, PhD⁴

¹haematology, Nantes university hospital, NANTES, France
²Hematology Clinic, Nantes University Hospital, Nantes, France
³CHU Nantes Hôpital Hôtel Dieu Hématologie Clinique, Nantes, France
⁴Hematology Department, Nantes University Hospital, Nantes, France

Nihar Desai, MBBS, MD, DM^1*, Tommy Alfaro Moya, MD^2*, Igor Novitzky-Basso, MD, PhD^3,4, Ivan Pasic, MD^5,6*, Wilson Lam, MD^5,6, Fotios Michelis, MD^5,6*, Armin Gerbitz, MD, PhD^3,6*, Auro Viswabandya, MD^3,6, Dennis Dong Hwan Kim, MD, PhD^6,7, Rajat Kumar, MD PhD^5,6, Jonas Mattsson, MD, PhD^6,8* and Arjun Law, MD^6,9

¹Princess Margaret Cancer Center, Lucknow, India
²Princess Margaret Cancer Center, Toronto, Canada
³Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
⁴Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada
⁵Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada, Toronto, ON, Canada
⁶Department of Medicine, University of Toronto, Toronto, ON, Canada
⁷Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
⁸Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada
⁹Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada, Toronto, Canada

Annalisa Paviglianiti^1*, Estefanía Pérez López, MD^2*, Alejandro Avendaño Pita^2*, Monica Baile Gonzalez^2*, Candela Ceballos Bolaños, MD^3*, Itziar Oiartzabal Ormategui, MD^3*, Albert Esquirol, MD^1,4*, Irene García-Cadenas, MD^1*, Maria Queralt Salas^5*, Sara Fernandez-Luis, MD^6*, Juan Dominguez Garcia, MD^7*, Inmaculada Heras, MD^8*, Alberto Mussetti^9*, Lucia García Mañó^10*, Tamara Torrado Chedas^11*, Sara Villar, MD^12*, Alberto Lopez Garcia, MD¹³, Adolfo Jesús Sáez Marín, MD^14*, Ana Pilar Gonzalez, MD^15* and Maria Jesus Pascual^16*

¹Hematology Department, Hospital de la Santa Creu i Sant Pau, IIB Sant Pau and José Carreras Leukemia Research Institutes, Universitat Autónoma de Barcelona, Barcelona, Spain
²Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca (IBSAL), Centro de Investigación del Cancer (IBMCC-USAL, CSIC), Salamanca, Spain
³Hematology Department, Hospital Universitario de Donosti, Donosti, Spain
⁴Hematology and Hemotherapy Department, Hospital de la Sant Creu i Sant Pau. IIB-Sant Pau and José Carreras Leukemia Research Institutes. Universitat Autónoma de Barcelona, Barcelona, Spain
⁵Hematology department, Hospital Clínic de Barcelona, Barcelona, Spain
⁶Hospital Universitario Marqués de Valdecilla (IDIVAL), Santander, Spain
⁷University Hospital MarquéS De Valdecilla - IDIVAL, Santander, Spain
⁸Hematology Division, Hospital Morales Meseguer, Murcia, Spain
⁹Clinical Hematology Department, Institut Català d’Oncologia-Hospitalet, IDIBELL, Barcelona, Spain
¹⁰Hematology Department., Hospital Universitario Son Espases, IdISBa., Palma, Spain
¹¹Hematology department, Hospital Universitario de A Coruña, A Coruña, Spain
¹²Hematology and Cell Therapy Department. Clinica Universidad de Navarra. IdiSNA., Pamplona, Spain
¹³Fundacion Jimenez Diaz University Hospital, Madrid, Spain
¹⁴University of Complutense, Hospital 12 de Octubre, Madrid, Spain
¹⁵Hospital Universitario Central de Asturias, Oviedo, Spain
¹⁶Hospital Regional Universitario de Málaga, Malaga, Spain

Jessica S. Little, MD^1,2,3*, Kyle Hebert, MS^4*, Donna S. Neuberg, ScD⁴, Sarah Nikiforow, MD, PhD^5,6, Mahasweta Gooptu, MD⁶, Roman M. Shapiro, MD^5,6, John Koreth, MD, MBBS, PhD, DPhil^5,6, Joseph H. Antin, MD^5,6, Corey S. Cutler, MD, MPH^6,7, Robert J. Soiffer, MD^6,8, Jerome Ritz, MD^6,7, Rizwan Romee, MD^5,6, Vincent T. Ho, MD^6,7*, Nicolas C Issa, MD^2,9,10*, Lindsey R. Baden, MD^2,7,11*, Remy Dulery, MD, PhD^6,7,12* and Susan E Prockop, MD^6,13*

¹Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA
²Harvard Medical School, Boston
³Department of Medical Oncology, Dana-Farber Center Institute, Boston, MA
⁴Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
⁵Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
⁶Harvard Medical School, Boston, MA
⁷Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
⁸Dana-Farber Cancer Inst., Boston, MA
⁹Department of Medical Oncology, Dana-Farber Cancer Institute, Boston
¹⁰Division of Infectious Diseases, Brigham & Women's Hospital, Boston, MA
¹¹Division of Infectious Diseases, Brigham and Women's Hospital, Boston
¹²Clinical Hematology and Cellular Therapy, Sorbonne University, Saint-Antoine Hospital, Assistance Publique - Hôpitaux de Paris, INSERM UMRs 938, Paris, Île-de-France, France
¹³Stem Cell Transplant Program, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA

Miriam Klahr, MD^1*, Amer Assal, MD², Ran Reshef, MD, MSc³, Samuel S. Pan, MSc^4*, Monica Bhatia, MD^5*, Diane George, MD^6* and Markus Y Mapara, MD⁷

¹Columbia University Irving Medical Center, Bronx, NY
²Columbia University Irving Medical Center, New York, NY
³Columbia Center for Translational Immunology, Columbia University Irving Medical Center, New York, NY
⁴Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY
⁵Division of Hematology, Oncology, and Stem Cell Transplant, Morgan Stanley Children’s Hospital, Columbia University, New York, NY, USA, New York, NY
⁶Columbia University Medical Center, New York, NY
⁷Department of Medicine, Division of Hematology & Oncology, Columbia University, New York

Emily Lekah, Pharm.D.^1*, Kristina Nelson, Pharm.D.^1*, Ryan Shanley, MS^2* and Alex Hoover, MD³

¹Department of Pharmacy, University of Minnesota Masonic Children's Hospital, Minneapolis, MN
²Biostatistics Core, Masonic Cancer Center, University of Minnesota, Minneapolis, MN
³Division of Blood and Marrow Transplantation and Cellular Therapy, University of Minnesota, Rosemount, MN

Michelle L Schoettler, MD^1*, Ritu Sachdeva, MD^2*, Muna Qayed, MD³, Benjamin Watkins, MD⁴, Suhag Parikh, MD^5*, Kathryn Leung^6*, Elizabeth O Stenger, MD, MSc⁷, Ann Haight, MD⁸, Katherine Silvis^9*, Yvonne Suessmuth^10*, Adrianna Westbrook^11* and Kirsten M. Williams, MD⁵

¹Emory University, Children’s Healthcare of Atlanta, Aflac Cancer and Blood Disorders Center, Atlanta, GA
²Children's Healthcare of Atlanta, Division of Cardiology, Atlanta, GA
³Division of Pediatric Hematology, Oncology and Bone Marrow Transplantation, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA
⁴Tulane University, New Orleans
⁵Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University, Atlanta, GA
⁶Aflac Cancer and Blood Disorders, Children's Healthcare of Atlanta, Emory University, Atlanta, GA
⁷Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta/Emory University, Atlanta, GA
⁸Children's Healthcare of Atlanta, Aflac Cancer and Blood Disorders Center, Atlanta, GA
⁹Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta and, Atlanta, GA
¹⁰Emory University, Transplant Center, Atlanta, GA
¹¹Emory University Hospital, Atlanta, GA

Lucia Castilla Garcia^1*, Rebeca Bailen^2*, Ignacio Alberto Gomez Centurion Luna^3*, Paula Fernández-Caldas^4*, Pablo Silva De Tena^2*, Carolina Martinez-Laperche, PhD^5,6*, Javier Anguita^7*, Ramon Garcia-Sanz, MD, PhD⁷ and Mi Kwon, MD, PhD⁷

¹Hospital General Universitario Gregorio Marañon, Madrid, Spain
²Hospital General Universitario Gregorio Marañón, Madrid, Spain
³Hospital General universitario Gregorio Marañon, MADRID, ESP
⁴Hematology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain
⁵Department of Hematology, Hospital Universitario Gregorio Marañón, Madrid, Spain
⁶Instituto de Investigación Sanitaria Hospital General Universitario Gregorio Marañón, Madrid, Spain
⁷General University Hospital Gregorio Marañón, Madrid, Spain

Rima M. Saliba, PhD^*, Yosra M. Aljawai, MD, MS, Amin M. Alousi, MD^*, Betul Oran, MD, MS, Uday Popat, MD, Richard E. Champlin, MD and Elizabeth J. Shpall, MD

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX

Alicia Bao, MD^1*, Xia Bi, MD^2*, Allison Gradone, MD^3*, Boula Gattas, MD^4*, Arpona Dev Nath, MD^5*, Brenda Grande^3*, Gina Mateja^3*, Joanne Filicko-O'Hara, MD², William O'Hara, PharmD^3*, John Wagner, MD^3*, Dolores Grosso, DNP^6*, Neal Flomenberg, MD^3* and Usama Gergis, MD, MBA²

¹Thomas Jefferson University, Philadelphia, PA
²Department of Bone Marrow Transplant and Cellular Therapy, Sidney Kimmel Cancer Center of Thomas Jefferson University, Philadelphia, PA
³Thomas Jefferson University, Philadelphia
⁴Thomas Jefferson University, Fairless Hills, PA
⁵Thomas Jefferson University Hospital, Philadelphia, PA
⁶Tevogen Bio, Warren, NJ

Jaehyun Ahn^1,2*, Jae-Ho Yoon, MD, PhD^2,3, Daehun Kwag^2,3*, Gi June Min, MD, PhD^2,3, Sung-Soo Park, MD, PhD^2,3*, Silvia Park, MD, PhD^2,3*, Sung-Eun Lee, MD, PhD^2,3*, Byung-Sik Cho^2,3*, Ki-Seong Eom, MD, PhD^3*, Yoo-Jin Kim³, Hee-Je Kim^2,3, Chang-Ki Min^3*, Seok-Goo Cho^3* and Seok Lee, MD^2,3

¹The Catholic University of Korea, Seoul, South Korea
²Leukemia Research Institute, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
³Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)

Benjamin H Mullish, PhD, MA, MRCP^1*, Andrew J Innes, MD, PhD^2*, Rohma Ghani, PhD^3*, Shian Anim-Burton, MSc, BS^4*, Lee Webber, BA^4*, Graham Wheeler, MSc PhD^4*, Nicholas A Johnson, BSc MSc^5*, Lauren Roberts, MSc^6*, Frances J Davies, PhD^7*, Julian R Marchesi, PhD^6* and Jiri Pavlu, MD, FRCPath, MRCP²

¹Imperial College London, London, ENG, United Kingdom
²Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom
³Department of Infectious Diseases, Imperial College Healthcare NHS Trust, London, United Kingdom
⁴Cancer Research UK Imperial Centre, Clinical Trials Section, Department of Surgery and Cancer, Imperial College London, London, United Kingdom
⁵School of Public Health, Faculty of Medicine, Imperial College London, London, United Kingdom
⁶Division of Digestive Diseases, Imperial College London, London, United Kingdom
⁷Department of Infectious Diseases, Imperial College NHS Healthcare Trust, LONDON, United Kingdom